United States: Protecting Payment For Value – OIG And CMS Propose New AKS Safe Harbors And Stark Exceptions

On October 9, 2019, the U.S. Department of Health and Human Services Office of the Inspector General ("OIG") and Centers for Medicaid & Medicare Services ("CMS") released their long-awaited proposed rules describing potential changes to regulations implementing the federal anti-kickback statute (the "AKS"), beneficiary inducement provisions of the civil monetary penalty law (the "CMPL"), and the physician self-referral law (the "Stark Law"). OIG and CMS have described the changes as efforts to reduce barriers to the coordination and delivery of value-based care.

The proposed rulemakings each include three new provisions for value-based care arrangements presenting different financial risk profiles.

This is our executive summary of the proposed rules. Our detailed analysis is available here.

Proposals to Protect Certain Value-Based Care Arrangements

There are three distinct proposed safe harbors and exceptions that would protect remuneration between a "value-based participant" and a "value-based entity" (or "value-based enterprise") pursuant to a "value-based arrangement."

What is a value-based participant? It's an individual or entity that engages in at least one value-based activity as part of a "value-based entity" (in OIG's words) or "value-based enterprise" (in CMS's words). OIG proposes that it cannot include a pharmaceutical manufacturer; manufacturer, distributor, or supplier of durable medical equipment, prosthetics, orthotics, or supplies; or laboratory. OIG might also exclude pharmacies; pharmacy benefit managers; pharmaceutical wholesalers/distributors; and medical device companies. CMS is considering exclusions.

What is a value-based entity? It's a group of at least two value-based participants that collaborate to achieve a value-based purpose under a value-based arrangement. It must have an accountable body (e.g., a board) and a governing document. OIG and CMS may consider further requirements, including requirements for the accountable body to have a duty of loyalty to the value-based entity.

What is a value-based arrangement? It's an arrangement providing for a value-based activity (e.g., coordinating and managing care, improving quality of care, reducing costs or expenditures of payors without reducing quality of care, and transitioning to healthcare and payment mechanisms based on quality of care and cost control) for a target patient population (which must be identified in advance, and might be subject to other limitations).

What would be protected? OIG proposes that remuneration must be either (i) primarily used for value-based activities directly connected to coordination and management of care, or (ii) directly connected to one or more value-based purposes. CMS does not propose similar requirements.

The three proposals vary based on the level of risk that parties assume.

The care coordination proposal would protect only in-kind remuneration under the AKS, but both in-kind and monetary remuneration under Stark. In each case, protection would be available for arrangements not involving downside financial risk. OIG would require recipients to contribute to at least some of the cost. OIG and CMS would require arrangements to be commercially reasonable for the value-based arrangement.

The substantial downside risk proposal would protect in-kind and monetary remuneration. Eligibility would require participants to bear downside risk (8% under the OIG proposal; 25% under the CMS proposal for Stark).

The full financial risk proposal also would protect in-kind and monetary remuneration. It would require, as implied, assumption of full financial risk.

There also is an OIG (but not CMS) proposal that would cover arrangements between parties in a CMS-sponsored model, program, or other initiative.

Other Value-Based Proposals

Modifications to EHR Safe Harbor/Exception. OIG and CMS would extend protection beyond December 31, 2021. The agencies also would cover replacement technology, and might make further changes.

Cybersecurity Technology Safe Harbor/Exception. OIG and CMS would permit donors to provide cybersecurity technology without recipient cost-sharing.

Personal Services Safe Harbor. OIG would provide safe harbor protection for arrangements with formulas that are set in advance, even if aggregate compensation is not. OIG also might add specific protection for outcomes-based payments (e.g., gainsharing payments).

Warranties Safe Harbor. OIG might expand this safe harbor to protect warranties on bundles of related items and services—but, protection would require that all federally reimbursable items in a bundle be reimbursed under the same federal health care program, in the same payment. Protection also would be limited to the cost of the product(s) under the warranty.

Patient Engagement. OIG proposes a new safe harbor to protect certain arrangements for in-kind (not cash) patient engagement tools and support to improve quality, health outcomes, and efficiency—if furnished by VBE participants to patients in a target patient population. OIG is considering an array of revisions to this proposal.

Unrelated Changes to the Stark Law

Most changes respond to issues and arguments that CMS has encountered through the self-disclosure protocol.

Designated Health Services ("DHS"). The rule would define DHS to include inpatient services only if the services affect the amount of Medicare's payment to the hospital under the Acute Care Hospital Inpatient Prospective Payment System ("IPPS").

Commercially Reasonable. Many Stark Law regulations have long required that arrangements must be commercially reasonable in the absence of referrals. CMS has proposed to define "commercially reasonable" to mean that a particular arrangement furthers a legitimate business purpose of the parties, and is on similar terms and conditions as like arrangements. CMS acknowledges in the commentary that an arrangement may be commercially reasonable even if it does not result in profit for one or more of the parties.

Fair Market Value. CMS also proposes to revise the definitions of "fair market value" and "general market value." These changes would remove current language that limits them not just to the result of bona fide bargaining between the parties, but to between parties "who are not otherwise in a position to generate business for the other party." However, the commentary minimizes the impact of this change.

"Volume or Value of Referrals" Standard. This would consider an arrangement to "take into account" the volume or value of referrals only when (i) the mathematical formula used to calculate the amount of compensation includes as a variable referrals or other business generated, and (ii) the amount of compensation correlates with the number or value of referrals generated by the physician or the generation of other business for the entity.

Group Practice Definition. One change would make clear that a profit share cannot include profits from fewer than all of the designated health services that a group provides. This is particularly relevant for groups establishing bonuses targeted for just certain lab services or DME that a group furnishes. Another change would provide some flexibility for groups to distribute revenue earned under a value-based arrangement to group members in a volume-sensitive manner.

Grace Period for Writing. CMS proposes a 90-day grace period for the writing requirement (not just the signature requirement, as exists now).

De Minimis Compensation. CMS proposes a new exception for remuneration to physicians not exceeding $3,500/year (among other requirements).

Current Stark Law Policy. CMS articulates a number of points of current agency policy and interpretation.

Isolated Transitions. CMS does not consider a "transaction" (for purposes of the isolated transactions exception) to include a single payment made for multiple services provided over an extended period of time.

Mid-Course Corrections. CMS does recognize that parties who detect and correct administrative or operational errors or discrepancies (e.g., payment inconsistent with a contract) can cure the errors in the arrangement if it is still active (but cannot do so after the relationship has ended).

Electronic Signatures. CMS considers an electronic signature that is legally valid under federal or state law to be sufficient to satisfy any Stark Law exception signature requirements.

Internal Notes. CMS states that, depending on the circumstances, the obligation to document that a compensation formula was set in advance can be satisfied through "informal communications via email or text, internal notes to file, similar payments between the parties from prior arrangements, generally applicable fee schedules," or documents used by physicians in similar situations.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Wilson Sonsini Goodrich & Rosati
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Wilson Sonsini Goodrich & Rosati
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions